An In-Depth View of Akzo Nobel Including its 64 Partnering Companies, and the 53 Deals the Company Made from 2000 - 2005.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26634 ) has announced the addition of Akzo Nobel Deals Briefing to their offering.

Description

Akzo Nobel Deals briefing provides an in-depth view of the 53 deals made by Akzo Nobel and its subsidiaries with 64 partnering companies between 2000 and 2005, in a clear and accessible PDF format.

Chapter 1: Company profile

--An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

--A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

--A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

--A detailed listing of all the company's deals and alliances announced between January 2000 and July 2005.

Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Scope

The report contains:

--a brief company profile including subsidiary names

--financial information where disclosed

--a deals overview

--specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage

--a detailed listing of the company's deals and alliances.

Key questions answered

--Akzo Nobel Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

--identifying active partners

--tracking competitor activity

--benchmarking deals

--comparing the finances of different deal types.

Akzo Nobel Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Akzo Nobel.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

Who should buy this report

--This report is essential reading for board and executive management, and individuals in:

--business development

--licensing/partnering

--deal making

--business strategy

--marketing and promotion

--distribution and manufacturing (including contract services).

Topics Covered

--Introduction

--About Partneringdesk Deals briefings

--Chapter 1: Company profile

--Chapter 2: Financial data and deals overview

--Chapter 3: Summary of deals

--Deals involving Akzo Nobel by partner company

--Deals involving Akzo Nobel by subsidiary

--Deals involving Akzo Nobel by therapy focus

--Deals involving Akzo Nobel by development stage

--Chapter 4: List of deals

--Glossary

List of Tables

--Table 2.1 Akzo Nobel financial summary

--Table 2.2 Akzo Nobel deals by deal type

--Table 2.3 Akzo Nobel deals by therapy focus

--Table 2.4 Akzo Nobel deals by development stage

--Table 2.5 Akzo Nobel deals by industry sector

Companies Mentioned

--Covance Biotechnology Services Inc

--Diosynth

--Intervet International

--Intervet Nederland BV

--Nippon Organon KK

--Nobilon International BV

--Organon

--Organon Canada

--Organon Teknika

--Rosemont Pharmaceuticals Ltd (until 2002-09-01)

For more information visit http://www.researchandmarkets.com/reports/c26634.